RNAi News GenomeWeb News Premium Content Existing subscribers login here. New to RNAi News? For a trial subscription click here.

With Phase I SBIR Grant, AM Biotechnologies
Looks to Apply Thioaptamer Tech to siRNAs

[July 17, 2008]

By Doug Macron

The $199,999 award from the National Institute of General Medical Sciences will help the company develop its core thioaptamer technology for synthesizing modified RNA oligonucleotides, including siRNAs.

Login | Subscribe